Decreased Orai1-mediated SOCE, either by gene knockdown or pharmacological channel blockers, is able to reduce the frequency of intracellular Ca2+ oscillations in cultured ESCC cells and to inhibit tumor growth in preclinical animal models. Here, ORAI1 is linked to neoplasm.